CytomX Therapeutics Earnings Surprises image   This CTMX earnings surprises page last updated 3/25/2024
CytomX Therapeutics Earnings Surprises Chart
PeriodExpectedActualSurprise
Q4 2023 -0.03 0.01 +0.04 (-133%)
Q3 2023 -0.19 0.04 +0.23 (-121%)
Q2 2023 -0.20 -0.02 +0.18 (-90%)
Q1 2023 -0.11 -0.05 +0.06 (-55%)
Q4 2022 -0.24 -0.42 -0.18 (+75%)
Q3 2022 -0.31 -0.35 -0.04 (+13%)
Q2 2022 -0.36 -0.37 -0.01 (+3%)
Q1 2022 -0.36 -0.37 -0.01 (+3%)
Q4 2021 -0.28 -0.40 -0.12 (+43%)
Q3 2021 -0.31 -0.35 -0.04 (+13%)
Q2 2021 -0.32 -0.30 +0.02 (-6%)
Q1 2021 -0.35 -0.26 +0.09 (-26%)
Q4 2020 -0.50 -0.31 +0.19 (-38%)
Q3 2020 -0.48 -0.32 +0.16 (-33%)
Q2 2020 0.16 -0.34 -0.50 (-312%)
Q1 2020 -0.46 0.26 +0.72 (-157%)
Q4 2019 -0.47 -0.79 -0.32 (+68%)
Q3 2019 -0.51 -0.52 -0.01 (+2%)
Q2 2019 -0.57 -0.64 -0.07 (+12%)
Q1 2019 -0.53 -0.31 +0.22 (-42%)
Q4 2018 -0.48 -0.74 -0.26 (+54%)
Q3 2018 -0.44 -0.53 -0.09 (+20%)
Q2 2018 -0.32 -0.35 -0.03 (+9%)
Q1 2018 -0.45 -0.40 +0.05 (-11%)
Q4 2017 -0.46 0.03 +0.49 (-107%)
Q3 2017 -0.15 -0.28 -0.13 (+87%)
Q2 2017 0.49 -0.69 -1.18 (-241%)
Q1 2017 -0.51 -0.23 +0.28 (-55%)
Q4 2016 -0.36 -0.39 -0.03 (+8%)
Q3 2016 -0.35 -0.40 -0.05 (+14%)
Q2 2016 -0.41 -0.39 +0.02 (-5%)
Q1 2016 -0.26 -0.44 -0.18 (+69%)
Q4 2015 -0.20 -0.39 -0.19 (+95%)
Q3 2015 -0.20 -14.26 -14.06 (+7030%)
CytomX Therapeutics Revenue Surprises Chart
PeriodExpectedActualSurprise
Q4 2023 21.04M 26.61M +5.57M (+26%)
Q3 2023 14.14M 26.38M +12.24M (+87%)
Q2 2023 13.88M 24.72M +10.84M (+78%)
Q1 2023 19.59M 23.50M +3.91M (+20%)
Q4 2022 17.85M 946000 -16.90M (+5299620%)
Q3 2022 17.94M 16.91M -1.02M (-6%)
Q2 2022 17.90M 18.16M +265000 (+1%)
Q1 2022 20.66M 17.14M -3.52M (-17%)
Q4 2021 24.51M 19.73M -4.78M (-20%)
Q3 2021 18.08M 17.59M -0.49M (-3%)
Q2 2021 16.86M 16.29M -0.57M (-3%)
Q1 2021 15.43M 15.97M +541000 (+3%)
Q4 2020 15.41M 16.37M +963000 (+6%)
Q3 2020 16.34M 17.79M +1.45M (+9%)
Q2 2020 48.21M 16.61M -31.60M (-66%)
Q1 2020 19.88M 49.59M +29.71M (+149%)
Q4 2019 17.44M 8.28M -9.16M (-53%)
Q3 2019 18.06M 10.71M -7.35M (-41%)
Q2 2019 16.58M 9.01M -7.57M (-46%)
Q1 2019 12.87M 29.48M +16.61M (+129%)
Q4 2018 15.71M 11.47M -4.24M (-27%)
Q3 2018 16.04M 12.51M -3.53M (-22%)
Q2 2018 19.22M 21.34M +2.12M (+11%)
Q1 2018 16.40M 14.18M -2.22M (-14%)
Q4 2017 10.10M 27.07M +16.97M (+168%)
Q3 2017 18.32M 24.14M +5.82M (+32%)
Q2 2017 4.09M 8.75M +4.66M (+114%)
Q1 2017 4.00M 11.65M +7.65M (+191%)
Q4 2016 6.19M 6.27M +82000 (+1%)
Q3 2016 5.09M 3.45M -1.64M (-32%)
Q2 2016 2.57M 3.09M +524000 (+20%)
Q1 2016 4.09M 2.22M -1.87M (-46%)
Q4 2015 1.89M 1.99M +98000 (+5%)
Q3 2015 1.89M 1.94M +49000 (+3%)
Quotes delayed 20 minutes

Email EnvelopeFree CTMX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options

Next Earnings Date Calendar:

Radiant Logistics (RLGT): 3/25/2024 8:00 AM
Theriva Biologics (TOVX): 3/25/2024 8:00 AM
Bitcoin Depot (BTM): 3/25/2024 8:05 AM
BuzzFeed (BZFD): 3/25/2024 After close
Lucid Diagnostics (LUCD): 3/25/2024 After close
Rekor Systems (REKR): 3/25/2024 After close
Sanara MedTech (SMTI): 3/25/2024 After close
Ampco-Pittsburgh (AP): 3/25/2024 After close
Excelerate Energy (EE): 3/25/2024 5:00 PM
Granite Ridge Resources (GRNT): 3/25/2024 5:00 PM

More from the Next Earnings Dates Calendar

Earnings History:

Tandy Leather Factory (TLF): 3/22/2024 After close
Moleculin Biotech (MBRX): 3/22/2024 After close
Luther Burbank (LBC): 3/22/2024 After close
Zymeworks (ZYME): 3/22/2024 After close
Pliant Therapeutics (PLRX): 3/22/2024 After close
Union Bankshares (UNB): 3/22/2024 2:00 PM
Solitario Zinc (XPL): 3/22/2024 9:30 AM
United-Guardian (UG): 3/22/2024 9:00 AM
Star Equity Hldgs (STRR): 3/22/2024 8:30 AM
Servotronics (SVT): 3/22/2024 8:30 AM

More from the Earnings History archive
CytomX Therapeutics (CTMX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

CTSO Historical Earnings
CTXR Historical Earnings
CUE Historical Earnings
CUTR Historical Earnings
CVRX Historical Earnings
CVS Historical Earnings
CWBR Historical Earnings
CYCC Historical Earnings
CYCN Historical Earnings
CYH Historical Earnings
On this page we presented the CTMX earnings surprises information for CytomX Therapeutics, comparing the expected earnings versus the actual earnings quarter by quarter, with the resulting positive or negative percentage surprise. Any self directed investor doing their due diligence on CTMX (or any other given stock) can benefit from researching all of the CytomX Therapeutics past earnings going backwards in time, including how often the company beat or missed the market's expectations. To help you with this CytomX Therapeutics earnings surprise research, on this page we presented each quarter's resulting numbers for easy comparison. Studying these numbers can help an investor by providing important context with which to think about CTMX's next earnings report. In your continued research on CytomX Therapeutics we hope you will be sure to check out the further links included for revenue and earnings history as well as next earnings dates for CTMX. Thanks for visiting, and the next time you need to research CTMX earnings surprises or those of another stock, we hope you'll think of our site as your go-to earnings surprises research resource of choice.

Recommended: Top Ten Hedge Funds Holding YETI, Funds Holding BDXB, HIFS Next Dividend Date.

 

CytomX Therapeutics Earnings Surprises | www.NextEarningsDate.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in NextEarningsDate.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.